Equities

Eiger BioPharmaceuticals Inc

Eiger BioPharmaceuticals Inc

Actions
  • Price (EUR)9.00
  • Today's Change-0.65 / -6.74%
  • Shares traded130.00
  • 1 Year change-32.84%
  • Beta1.4460
Data delayed at least 15 minutes, as of Jan 15 2021 20:52 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Key statistics

On Friday, Eiger BioPharmaceuticals Inc (72C1:DEU) closed at 9.00, -32.84% below its 52-week high of 13.40, set on Jan 16, 2020.
52-week range
Today
4.32Mar 16 202013.40Jan 16 2020
Markit short selling activity
Low
Med
High
Open9.60
High9.95
Low9.00
Bid8.95
Offer9.30
Previous close9.65
Average volume1.47k
Shares outstanding32.53m
Free float31.98m
P/E (TTM)--
Market cap368.58m USD
EPS (TTM)-2.44
USD
Data delayed at least 15 minutes, as of Jan 15 2021 20:52 GMT.
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.